Two-peptide repair blend
Wolverine Stack
BPC-157 + TB-500 - an informal name, not a formulation
Wolverine stack is a market-given name, not a research one. It describes pairing BPC-157 with TB-500 on the promise of faster tissue repair. The name came from online forums and vendor catalogues, which means there is no standard ratio to check a vial against - some suppliers even add GHK-Cu and keep the name.
The two components are studied separately and at different stages. Treating them as one product obscures that, and it makes verification harder: a single aggregate purity figure on a blend certificate does not prove both peptides are present at the stated ratio.
Regulatory status
Neither component is FDA-approved for any human indication. The FDA removed both from the 503A Category 2 list in April 2026, and the Pharmacy Compounding Advisory Committee reviewed them on 23 July 2026, voting 8-6 to recommend each. That vote is a procedural step, not an approval, and neither is legal to compound while rulemaking continues. TB-500 is prohibited by the World Anti-Doping Agency, which matters for any tested athlete.
Composition
Mechanism
The stacking rationale
BPC-157 is proposed to act mainly through angiogenesis and collagen synthesis; TB-500 through cell migration and actin polymerisation. The hypothesis is that getting blood supply to damaged tissue and moving repair cells there could be additive. It is a plausible hypothesis that has not been tested.
BPC-157 component
The more heavily studied of the two. Rodent tendon, ligament, and gastrointestinal injury models dominate, with vascular signalling the most commonly proposed route.
TB-500 component
A fragment of thymosin beta-4, which regulates actin. Most of the human evidence cited for it actually comes from the full-length parent protein, not the fragment - the two are not interchangeable when reading research.
Research status
No published clinical trial has tested BPC-157 and TB-500 together in humans, and none has compared the combination against either compound alone, so the synergy claim is untested rather than disproven. BPC-157's human data amounts to a small case series in chronic knee pain and a two-person IV pilot; a 2025 review of the preclinical literature noted that none of the studies it examined included clinical safety evidence. TB-500's strongest human signal is on its parent molecule, including a Phase 2b trial in acute myocardial infarction and small trials in dry eye and pressure ulcers. The combined safety profile is essentially unknown, and because angiogenesis is part of the proposed mechanism, there are theoretical concerns relevant to active malignancy.
Verifying a batch
- 01A blend certificate needs two resolved peaks on a chromatogram, not one aggregate purity figure.
- 02Identity should be confirmed by mass spectrometry for each component separately, with the ratio quantified.
- 03Match the lot number on the certificate to the vial; a certificate for a different lot proves nothing about yours.
- 04The issuing lab should be named and independent - check that it exists.
Search lab reports for this compound →How purity is tested →
Questions
Is the Wolverine stack a real formulation?+
No. It is an informal name for combining two separately sold peptides. There is no standard ratio and no research designation behind the term.
Does stacking BPC-157 and TB-500 work better than either alone?+
That is untested. No study has compared the combination against either compound by itself in humans, so the additive effect is a hypothesis rather than a finding.
Why is it called the Wolverine stack?+
After the comic-book character's healing ability. The name originated in forums and vendor catalogues, not in published literature.
How do I verify a blend vial?+
Look for two resolved chromatogram peaks, mass spectrometry identity for each component, a quantified ratio, lot matching, and a named independent lab.
Related compounds
Looking for Wolverine Stack?
Join our next group buy to get verified quality at wholesale prices.
All compounds listed here are supplied for laboratory research use only and are not medicines, supplements, or products for human consumption.